Avalo Therapeutics Inc. (AVTX)
NASDAQ · Healthcare
Avalo Therapeutics Inc. Total Liabilities 2015–2025
Avalo Therapeutics Inc. annual total liabilities history from 2015 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Avalo Therapeutics Inc. total liabilities as of December 31, 2025: 33.4M, a 88.75% increase year-over-year.
- Avalo Therapeutics Inc. total liabilities for 2025 were 33.4M, a 88.75% increase from 2024.
- Avalo Therapeutics Inc. total liabilities for 2024 were 17.7M, a 29.30% increase from 2023.
- Avalo Therapeutics Inc. total liabilities for 2023 were 13.7M, a 69.09% decrease from 2022.
- Avalo Therapeutics Inc. total liabilities for 2022 were 44.3M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Avalo Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $33 |
| 2024 | $18 |
| 2023 | $14 |
| 2022 | $44 |
| 2021 | $57 |
| 2020 | $19 |
| 2019 | $15 |
| 2018 | $49 |
| 2017 | $15 |
| 2016 | $6 |
| 2015 | $9 |
Avalo Therapeutics Inc. Total Liabilities — FAQ
Avalo Therapeutics Inc. (AVTX) total liabilities over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVTX's total liabilities history?
The chart and table above show Avalo Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.